When, how, why and whom for there will be an "after" Covid-19?

被引:0
作者
Tognoni, Gianni [1 ]
机构
[1] Fdn IRCSS Ca Granda Osped Maggiore Policlin, Milan, Italy
关键词
Covid-19; clinical trials; outcomes;
D O I
10.1702/3454.34432
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The announced, but unpredicted, radical and global experience of the Covid-19 pandemia has revealed the degree of ignorance, fragmentation, inadequacy of the national and international knowledge and strategies of intervention and, even more substantially, of coordination across all the critical areas of prevention and care. The importance of the nursing component of the organisation and of the technical and cultural aspects of health care delivery and accessibility has been underlined as a protagonist of the resistance and resilience during the worst period of the emergency, and should be specifically involved in this renewal, where a profound modification of the interactions, hierarchies, roles of various professions is required. A long term, widespread, flexible experimentation of country specific and international solutions must be envisaged and timely activated. The 'grammar' and the major concrete characteristics of the methodology which could be usefully adopted to guarantee the feasibility and effectiveness of this 'systemic' experimentation are proposed and exemplified.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 50 条
  • [21] Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
    Lippi, Giuseppe
    Henry, Brandon Michael
    Plebani, Mario
    DIAGNOSTICS, 2021, 11 (06)
  • [22] ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing
    Kumar, Mukesh
    Iyer, Suri S.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021, 21 (04) : 349 - 362
  • [23] Building an Ethics Framework for COVID-19 Resource Allocation: The How and the Why
    Dawson, Angus
    JOURNAL OF BIOETHICAL INQUIRY, 2020, 17 (04) : 757 - 760
  • [24] Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
    Tiberghien, Pierre
    Lamballerie, Xavier de
    Morel, Pascal
    Gallian, Pierre
    Lacombe, Karine
    Yazdanpanah, Yazdan
    VOX SANGUINIS, 2020, 115 (06) : 488 - 494
  • [25] Building an Ethics Framework for COVID-19 Resource Allocation: The How and the Why
    Angus Dawson
    Journal of Bioethical Inquiry, 2020, 17 : 757 - 760
  • [26] When pneumonia is not COVID-19
    Arenas-Jimenez, J. J.
    Plasencia-Martinez, J. M.
    Garcia-Garrigos, E.
    RADIOLOGIA, 2021, 63 (02): : 180 - 192
  • [27] Novel Criteria for When and How to Exit a COVID-19 Pandemic Lockdown
    Li, Chenyu
    Romagnani, Paola
    Anders, Hans-Joachim
    FRONTIERS IN BIG DATA, 2020, 3
  • [28] Understanding How and by Whom COVID-19 Misinformation is Spread on Social Media: Coding and Network Analyses
    Zhao, Yuehua
    Zhu, Sicheng
    Wan, Qiang
    Li, Tianyi
    Zou, Chun
    Wang, Hao
    Deng, Sanhong
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2022, 24 (06)
  • [29] Excess mortality during the COVID-19 pandemic in Israel, March–November 2020: when, where, and for whom?
    Ziona Haklai
    Miriam Aburbeh
    Nehama Goldberger
    Ethel-Sherry Gordon
    Israel Journal of Health Policy Research, 10
  • [30] How Does COVID-19 Affect the Heart?
    Sewanan, Lorenzo R.
    Clerkin, Kevin J.
    Tucker, Nathan R.
    Tsai, Emily J.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (03) : 171 - 184